Acesso livre
Acesso livre

Cardiologia

Estudo de coorte | Características clínicas e história natural da cardiomiopatia hipertrófica não sindrômica em pré-adolescentes.

24 Mai, 2022 | 11:24h

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy – Journal of the American College of Cardiology

Comentário: Clinical Features and Course of Preadolescent Hypertrophic Cardiomyopathy – American College of Cardiology


Diretriz científica AHA | Prevenção e manejo de quedas em adultos com doença cardiovascular.

23 Mai, 2022 | 13:40h

Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation: Cardiovascular Quality and Outcomes

Comunicado de imprensa: Statement addresses ways to prevent heart-related risks for falling – American Heart Association

Comentário: AHA News: Falls Can Be a Serious, Poorly Understood Threat to People With Heart Disease – HealthDay


Diretrizes SCAI para tratamento do forame oval patente.

23 Mai, 2022 | 13:28h

SCAI Guidelines for the Management of Patent Foramen Ovale – JSCAI

Editorial: New SCAI Guidelines: Trying to Close the Holes in the PFO Literature – JSCAI

Comentário: PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups— Document acknowledges skimpy evidence – MedPage Today (free registration required)

Conteúdos relacionados:

Advances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology – Neurology

Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke – JAMA (link para o resumo – $ para o texto completo)

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases – Mayo Clinic Proceedings


Estudo randomizado | Apixaban não é superior ao cuidado padrão (antagonista de vitamina K e terapia antiplaquetária se a anticoagulação for ou não indicada, respectivamente) após implante de válvula aórtica transcateter.

23 Mai, 2022 | 13:27h

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial – European Heart Journal (link para o resumo – $ para o texto completo)

Editorial: Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS – European Heart Journal

Conteúdos relacionados:

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial – Circulation

Comparing Single- and Dual-Antiplatelet Therapies After Transcatheter Aortic Valve Implantation – The Annals of Thoracic Surgery

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis – Journal of the American Heart Association

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation – New England Journal of Medicine

Anti-Thrombotic Strategy to Lower All cardiovascular and Neurologic Ischemic and Hemorrhagic Events after Trans-Aortic Valve Implantation for Aortic Stenosis – ATLANTIS – American College of Cardiology


M-A | Tratamento da estenose aórtica grave assintomática.

23 Mai, 2022 | 13:23h

Management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis – openheart

 

Comentários no Twitter

 


Perspectiva | A necessidade de um maior pragmatismo nos estudo clínicos cardiovasculares.

20 Mai, 2022 | 14:00h

The need for increased pragmatism in cardiovascular clinical trials – Nature Reviews Cardiology (se o acesso a este link for pago, tente este)

Conteúdo relacionado: A roadmap of strategies to support cardiovascular researchers: from policy to practice – Nature Reviews Cardiology (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 


Prescrição de inibidores de SGLT2 em pacientes com doença renal crônica: indicações em expansão e considerações práticas.

20 Mai, 2022 | 13:56h

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations – Kidney International Reports

 

Comentário no Twitter

Sob licença de CC BY-NC-ND 4.0


Tratamento da hipertensão estágio 1: considerar os riscos, interromper a progressão.

20 Mai, 2022 | 13:28h

Managing stage 1 hypertension: Consider the risks, stop the progression – Cleveland Clinic Journal of Medicine


Estudo randomizado | Efeito do implante transcateter de valva aórtica vs. cirurgia sobre a mortalidade por todas as causas em pacientes com estenose aórtica.

19 Mai, 2022 | 13:16h

Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Treatment of Aortic Stenosis With Transcatheter Aortic Valve Implantation – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

 


M-A | Agonistas receptores do peptídio-1 glucagon-like (GLP-1) e eventos cardiovasculares em pacientes com diabetes melito tipo 2.

19 Mai, 2022 | 13:03h

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials – BMC Endocrine Disorders

 

Comentário no Twitter

Sob licença de http://creativecommons.org/licenses/by/4.0/


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.